| Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network |
| Author(s): Cederholm S, Hill G, Asiimwe A, Bate A, Bhayat F, Persson Brobert G, Bergvall T, Ansell D, Star K & Norén GN |
| Affiliations(s): Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring
|
| Publication(s): Drug Saf. 2015 Jan;38(1):87-100. doi: 10.1007/s40264-014-0251-y. |
| Document Type(s): Article |
| Countries: UK |
| Click here for the abstract |
C:
Y: |
Health policy, Miscellaneous
2015 |
|
L:
A: |
English
Retrospective database analysis |
|
 |
| |
| |
| Audit of irreversible monoamine oxidase inhibitor (MAOI) prescribing for depression in current clinical practice using The Health Improvement Network (THIN) UK primary care database |
| Author(s): Nasser A, O’Leary C, Myland M, Sam Waples S & Ansell D |
| Affiliations(s): IMS Health
|
| Publication(s): PRIMM conference, 26th Annual Scientific Meeting, Imperial Hotel, Russell Square, London
|
| Document Type(s): Poster |
| Countries: UK |
| Click here for the abstract |
C:
Y: |
Clinical practice, Health policy, Mental health
2015 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Longitudinal medical records as a complement to routine drug safety signal analysis |
| Author(s): Star K, Watason S, Sandberg L, Johansson J, Edwards IR |
| Affiliations(s): Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring
|
| Publication(s): Pharmacoepidemiology and Drug Safety published by John Wiley & Sons, Ltd.
24(5):486-94 |
| Document Type(s): Article |
| Countries: UK |
| Click here for the abstract |
C:
Y: |
Health policy, Methodology
2015 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN) |
| Author(s): Carbonari DM, Saine ME, Newcomb CW, Blak B, Roy JA, Haynes K, Wood J, Gallagher AM, Bhullar H, Cardillo S, Hennessy S, Strom BL & Lo Re V 3rd |
| Affiliations(s): Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania
|
| Publication(s): Pharmacoepidemiol Drug Safety
Volume 24, Issue 9, pages 999–1003, |
| Document Type(s): Article |
| Countries: UK |
| Click here for the abstract |
C:
Y: |
Health policy, Miscellaneous
2015 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Access to New Medicines in Public Drug Plans: Canada and Comparable Countries 2015 Annual Report |
| Author(s): Millson B1, Thiele S1, Zhang Y1, Dobson-Belaire W1, Skinner B2 |
| Affiliations(s): 1 IMS Health Canada Inc., 16720 Trans-Canada Highway, Kirkland, Quebec H9H 5M3
2 Innovative Medicines Canada, 55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5 |
| Publication(s): Innovative Medicines Canada Annual Report 2016 |
| Document Type(s): Report |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Health economics, Health policy
2015 |
|
L:
A: |
English
Review |
|
|
| |
| |
| (Supply profile of patients with occupational therapy regulations in their own practices) Versorgungsprofil der Patienten mit Ergotherapie-Verordnungen in niedergelassenen Praxen. |
| Author(s): Kostev K1, Drosselmeyer2, Jockwig A2, Hog D2, Heilmaier C3 |
| Affiliations(s): 1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 FOM University, Essen, Germany |
| Publication(s): Monitor Versorgungsforschung, 2014, Maerz. (02): |
| Document Type(s): Article |
| Countries: Germany |
C:
Y: |
Health policy
2014 |
|
L:
A: |
German
Economic evaluation |
|
|
| |
| |
| Quantification of switching trends in the Greek pharmaceutical market during the period of crisis |
| Author(s): Ollandezos M1, Charitonidis S2, Papadopoulos K1, Katsoulakis M2, Kofinas K2, Kyriopoulos J3 |
| Affiliations(s): 1Pan Hellenic Union of Pharmaceutical Industry, Athens, Greece, 2IMS Health Hellas, Athens, Greece, 3National School of Public Health, Athens, Greece |
| Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: Greece |
C:
Y: |
Health policy
2014 |
|
L:
A: |
English
Methodology |
|
|
| |
| |
| Generic penetration within top-10 genericized molecules – Greece versus major European countries |
| Author(s): Charitonidis S1, Kofinas K1, Katsoulakis M1, Papadopoulos K2, Ollandezos M2, Kyriopoulos J3 |
| Affiliations(s): 1IMS Health Hellas, Athens, Greece, 2Pan Hellenic Union of Pharmaceutical Industry, Athens, Greece, 3National School of Public Health, Athens, Greece |
| Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: Greece |
C:
Y: |
Health policy
2014 |
|
L:
A: |
English
Pricing & Reimbursement |
|
|
| |
| |
| Trends in time to market access in Europe - is it getting better? |
| Author(s): Flostrand SJ1, Lor S1, Anon Y2
|
| Affiliations(s): 1IMS Consulting Group, La Défense Cedex, France, 2IMS Health, La Défense Cedex, France |
| Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: |
C:
Y: |
Health policy, Pricing and reimbursement
2014 |
|
L:
A: |
English
Market impact |
|
|
| |
| |
| Trends in time to market access in Europe - is it getting better? |
| Author(s): Flostrand SJ1, Lor S1, Anon Y2
|
| Affiliations(s): 1IMS Consulting Group, La Défense Cedex, France, 2IMS Health, La Défense Cedex, France |
| Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: |
C:
Y: |
Health policy
2014 |
|
L:
A: |
English
Market impact |
|
|
| |
| |
 2 of 9 
|
